TSX:ACB - Toronto Stock Exchange - CA05156X8504 - Common Stock - Currency: CAD
TSX:ACB (2/21/2025, 7:00:00 PM)
8.34
+0.04 (+0.48%)
The current stock price of ACB.CA is 8.34 CAD. In the past month the price increased by 50.27%. In the past year, price increased by 89.98%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.91 | 3.76B | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 1.27B | ||
CRON.CA | CRONOS GROUP INC | N/A | 1.06B | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 4.95 | 677.85M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 560.43M | ||
DHT-U.CA | DRI HEALTHCARE TRUST | 3.5 | 478.55M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 400.51M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 14.04 | 319.88M | ||
HITI.CA | HIGH TIDE INC | N/A | 299.33M | ||
TSND.CA | TERRASCEND CORP | N/A | 271.02M | ||
OGI.CA | ORGANIGRAM HOLDINGS INC | N/A | 229.72M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 203.27M |
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. The company is headquartered in Leduc, Alberta and currently employs 1,073 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T9E 0V6 CA
CEO: Miguel Martin
Employees: 1073
Company Website: https://www.auroramj.com/
Investor Relations: https://www.auroramj.com/investors/
Phone: 16043625207
The current stock price of ACB.CA is 8.34 CAD. The price increased by 0.48% in the last trading session.
The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Toronto Stock Exchange exchange.
ACB.CA stock is listed on the Toronto Stock Exchange exchange.
10 analysts have analysed ACB.CA and the average price target is 10.2 CAD. This implies a price increase of 22.3% is expected in the next year compared to the current price of 8.34. Check the AURORA CANNABIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AURORA CANNABIS INC (ACB.CA) has a market capitalization of 457.53M CAD. This makes ACB.CA a Small Cap stock.
AURORA CANNABIS INC (ACB.CA) currently has 1073 employees.
AURORA CANNABIS INC (ACB.CA) has a support level at 8.33 and a resistance level at 8.82. Check the full technical report for a detailed analysis of ACB.CA support and resistance levels.
The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 25.87% in the next year. Check the estimates tab for more information on the ACB.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ACB.CA does not pay a dividend.
AURORA CANNABIS INC (ACB.CA) will report earnings on 2025-06-18, after the market close.
AURORA CANNABIS INC (ACB.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).
ChartMill assigns a technical rating of 9 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is one of the better performing stocks in the market, outperforming 92.35% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ACB.CA. The financial health of ACB.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 113.91% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.9% | ||
ROA | 1.44% | ||
ROE | 2.18% | ||
Debt/Equity | 0.07 |
ChartMill assigns a Buy % Consensus number of 72% to ACB.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -40.18% and a revenue growth 25.87% for ACB.CA